Leptin-to-adiponectin ratio as a potential atherogenic index in obese type 2 diabetic patients

Diabetes Care. 2004 Oct;27(10):2488-90. doi: 10.2337/diacare.27.10.2488.

Authors

Noriko Satoh¹, Mitsuhide Naruse, Takeshi Usui, Tetsuya Tagami, Takayoshi Suganami, Kazunori Yamada, Hideshi Kuzuya, Akira Shimatsu, Yoshihiro Ogawa

Affiliation

¹ Clinical Research Institute for Endocrine Metabolic Disease, Kyoto Medical Center, Japan.

PMID: 15451921
DOI: 10.2337/diacare.27.10.2488

No abstract available

Publication types

Comparative Study
Research Support, Non-U.S. Gov't

MeSH terms

Adiponectin
Age Factors
Arteriosclerosis / etiology*
Arteriosclerosis / prevention & control
Biomarkers / analysis
Body Composition
Body Mass Index
Cohort Studies
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / diagnosis*
Female
Humans
Intercellular Signaling Peptides and Proteins / analysis
Intercellular Signaling Peptides and Proteins / metabolism*
Leptin / analysis
Leptin / metabolism*
Male
Middle Aged
Obesity / complications
Obesity / diagnosis*
Probability
Prognosis
Prospective Studies
Reference Values
Risk Assessment
Sensitivity and Specificity
Severity of Illness Index
Sex Factors

Substances

Adiponectin
Biomarkers
Intercellular Signaling Peptides and Proteins
Leptin